European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Pharma Greven GmbH, Greven, Germany

Watch
Pharma Greven GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier is a comprehensive company details as a PDF and publications in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Complete Dossier
Entire company details along with publications bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans
Risk report
Pharma Greven GmbH
Risk Level Evaluation Source
Sanctioned (?)

Name

Pharma Greven GmbH

Identification

Ut
District Court of Steinfurt HRB 7075
Lei
529900O3M74Z63F5Y178
EUID
DER2706.HRB7075

Address

Hüttruper Heide 90, 48268 Greven, Germany

Corporate purpose

The export and import of pharmaceutical products as well as the trade in pharmaceutical goods of all kinds.

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
3Managing Director
1Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Cash on hand
Receivables
Liabilities
Pension provisions
Trademarks
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2007 to 2024
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

9 Jan 2026
Managing Director: Tomas Keisers · No longer Managing Director: Daniel Diaz-Varela
14 Jul 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024
31 Mar 2025
Original document: “Liste der Gesellschafter“
24 Jan 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023
29 Jul 2024
Managing Director: Daniel Diaz-Varela, Romeo Krebser, Marie-Theres Nadler · Authorized signatory (ppa): M. I. Hücking-Minder · No longer MD: Thomas Nadler · No longer ppa: Marie-Theres Nadler
23 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
20 Jun 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
3 May 2022
Managing Director: Daniel Diaz-Varela
12 Apr 2022
Original document: “Liste der Gesellschafter“
7 Apr 2022
Original document: “Liste der Gesellschafter“
2 Sept 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
6 Aug 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
29 May 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
13 Feb 2019
Authorized signatory (ppa): Marie-Theres Nadler · No longer Authorized signatory (ppa) (1)
4 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
4 Jan 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
6 Jan 2017
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
5 Dec 2016
Authorized signatory (ppa) (1)
4 Nov 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
8 Oct 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
1 Jul 2014
Word figurative mark: “pharma greven.“
9 Jan 2014
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
21 Jan 2013
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
18 Jan 2012
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
11 Jan 2011
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
7 Jul 2010
No longer Managing Director (1)
18 Mar 2010
Original document: “Liste der Gesellschafter“
24 Feb 2010
No longer Managing Director (1)
4 Feb 2010
Original document: “Gesellschaftsvertrag / Satzung / Statut“
19 Jan 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
3 Apr 2009
Address · Share­holder agreement
10 Mar 2009
Original document: “Liste der Gesellschafter“
10 Mar 2009
Original document: “Liste der Gesellschafter“
10 Mar 2009
Original document: “Gesellschaftsvertrag / Satzung / Statut“
4 Feb 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
30 Jan 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
12 May 2006
Managing Director: Thomas Nadler
26 Apr 2006
Managing Director: Thomas Nadler
17 Aug 2005
Reg­is­tra­tion · Managing Director (1) · Capital: €75,000 · Share­holder agreement · Proxy policy · Corporate Purpose
5 Aug 2005
Reg­is­tra­tion · Managing Director (1) · Capital: €75,000 · Seat: Greven · Legal form: GmbH · Name: Pharma Greven GmbH · Corporate Purpose
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.